Weitz Investment Management, an investment management firm, released its second-quarter Q2 2026 investor letter for the "Multi Cap Equity Fund". The letter can be downloaded here. The Multi Cap Equity Fund's Institutional Class returned 7.90% in Q2, underperforming the Bloomberg U.S. 3000 Index's 15.71% gain. Markets rose in the quarter on hopes of de-escalating Middle East tensions and easing oil flow. Investor focus shifted back to artificial intelligence, despite component shortages like processing chips affecting profits and valuations. Valuation-sensitive investors are selective within the AI sector, in contrast to valuation-agnostic indexes that adopt a more relaxed strategy. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Weitz Multi Cap Equity Fund highlighted Mettler-Toledo International Inc. (NYSE:MTD). Mettler-Toledo International Inc. (NYSE:MTD) manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. On September 15, 2026, Mettler-Toledo International Inc. (NYSE:MTD) closed at $1,330.40 per share. Over the past month, Mettler-Toledo International Inc. (NYSE:MTD) declined 6.64%, and its shares gained 4.43% over the past 52 weeks. Mettler-Toledo International Inc. (NYSE:MTD) has a market capitalization of $26.66 billion.
Weitz Multi Cap Equity Fund stated the following regarding Mettler-Toledo International Inc. (NYSE:MTD) in its Q2 2026 investor letter:
"Less familiar to shareholders may be our new position in Mettler-Toledo International Inc. (NYSE:MTD), a global supplier of precision measurement instruments across laboratory, industrial and food retailing applications where accuracy, reliability and regulatory compliance are vital. Its highly specialized sales and service organization is a key competitive advantage, working collaboratively with customers to optimize their workflows and improve productivity, reinforcing long-term customer relationships. We have long admired Mettler's business and purchased a small position during a brief period of price dislocation during the quarter."
Mettler-Toledo International Inc. (NYSE:MTD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 48 hedge fund portfolios held Mettler-Toledo International Inc. (NYSE:MTD) at the end of the second quarter, down from 50 in the previous quarter. While we acknowledge the potential of Mettler-Toledo International Inc. (NYSE:MTD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

#mettler #quarter

Weitz Investment Management, an investment management firm, released its second-quarter Q2 2026 investor letter for the "Multi Cap Equity Fund". The letter can be downloaded here. The Multi Cap Equity Fund's Institutional Class returned 7.90% in Q2, underperforming the Bloomberg U.S. 3000 Index's 15.71% gain. Markets rose in the quarter on hopes of de-escalating Middle East tensions and easing oil flow. Investor focus shifted back to artificial intelligence, despite component shortages like processing chips affecting profits and valuations. Valuation-sensitive investors are selective within the AI sector, in contrast to valuation-agnostic indexes that adopt a more relaxed strategy. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Weitz Multi Cap Equity Fund highlighted Mettler-Toledo International Inc. (NYSE:MTD). Mettler-Toledo International Inc. (NYSE:MTD) manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. On September 15, 2026, Mettler-Toledo International Inc. (NYSE:MTD) closed at $1,330.40 per share. Over the past month, Mettler-Toledo International Inc. (NYSE:MTD) declined 6.64%, and its shares gained 4.43% over the past 52 weeks. Mettler-Toledo International Inc. (NYSE:MTD) has a market capitalization of $26.66 billion.
Weitz Multi Cap Equity Fund stated the following regarding Mettler-Toledo International Inc. (NYSE:MTD) in its Q2 2026 investor letter:
"Less familiar to shareholders may be our new position in Mettler-Toledo International Inc. (NYSE:MTD), a global supplier of precision measurement instruments across laboratory, industrial and food retailing applications where accuracy, reliability and regulatory compliance are vital. Its highly specialized sales and service organization is a key competitive advantage, working collaboratively with customers to optimize their workflows and improve productivity, reinforcing long-term customer relationships. We have long admired Mettler's business and purchased a small position during a brief period of price dislocation during the quarter."
Mettler-Toledo International Inc. (NYSE:MTD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 48 hedge fund portfolios held Mettler-Toledo International Inc. (NYSE:MTD) at the end of the second quarter, down from 50 in the previous quarter. While we acknowledge the potential of Mettler-Toledo International Inc. (NYSE:MTD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

#Equity #fund #weitz

Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, the Fund appreciated 10.61% on an annualized basis, compared with 10.02% for the Benchmark and 14.83% for the Index. Strong stock selection in pharmaceuticals, biotechnology, health care equipment, and life sciences tools and services supported the Fund's outperformance, although limited exposure to managed care stocks reduced relative returns. The Fund remains positive on health care due to improving biotechnology funding, strong acquisition activity, recovering managed care margins, and growth from an aging population, chronic disease, medical innovation, and higher health care spending. In addition, please check the Fund's top five holdings to know the best picks in 2026.
In its second-quarter 2026 investor letter, Baron Health Care Fund highlighted Mettler-Toledo International Inc. (NYSE:MTD). Mettler-Toledo International Inc. (NYSE:MTD) manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. On August 03, 2026, Mettler-Toledo International Inc. (NYSE:MTD) closed at $1,445.00 per share. The one-month return of Mettler-Toledo International Inc. (NYSE:MTD) was 10.84%, and its shares gained 15.44% over the past 52 weeks. Mettler-Toledo International Inc. (NYSE:MTD) has a market capitalization of $28.95 billion..
Baron Health Care Fund stated the following regarding Mettler-Toledo International Inc. (NYSE:MTD) in its Q2 2026 investor letter:
"We added to our position in Mettler-Toledo International Inc. (NYSE:MTD), a company we have owned in the Fund since inception. Mettler is a leading global provider of precision instruments and services. The company's products are used in key R&D, quality control, and manufacturing processes for customers in the life sciences, food, and chemicals industries, among others. We believe Mettler has multiple competitive advantages, including its strong brand, product offering and large installed base; large direct sales and service network; global supply chain; sophisticated sales and marketing programs; longstanding local presence in fast growing emerging markets; and culture of operational excellence and execution. The company has a long track record of generating consistent earnings growth. In the quarter, Mettler's organic revenue growth rate and guidance were slightly below expectations. We thought the negative stock reaction was way overblown, leading to a valuation the stock had not seen in many years. We are confident that over the long-term Mettler can generate mid-teens or better annual earnings growth."

#toledo

With a market cap of $26.2 billion, Mettler-Toledo International Inc. (MTD) is a leading global provider of precision instruments and services, recognized for its innovation and strong market leadership across a wide range of industries, including life sciences, food, and chemicals. With products sold in more than 140 countries and a direct presence in approximately 40 countries, the company supports critical research, quality control, and manufacturing processes through an extensive global sales and service network.
The Greifensee, Switzerland-based company is set to unveil its fiscal Q2 2026 results after the market closes on Thursday, Jul. 30. Ahead of the event, ******* ysts forecast MTD to post an adjusted EPS of $10.78, a growth of 6.8% from $10.09 in the same quarter last year. The company has surpassed Wall Street's bottom-line projections in each of the past four quarters.
Nasdaq Futures Plunge as Samsung Sparks Chip Selloff
AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years
The Nasdaq-100 Could Be Forming a Textbook Diamond Top. Here's What to Watch on the QQQ Chart Now.